MDT

82.73

-3.85%↓

A

121.14

+0.35%↑

VEEV

167.39

-1.4%↓

HQY

85.47

-0.71%↓

NEOG

9.39

-1.78%↓

MDT

82.73

-3.85%↓

A

121.14

+0.35%↑

VEEV

167.39

-1.4%↓

HQY

85.47

-0.71%↓

NEOG

9.39

-1.78%↓

MDT

82.73

-3.85%↓

A

121.14

+0.35%↑

VEEV

167.39

-1.4%↓

HQY

85.47

-0.71%↓

NEOG

9.39

-1.78%↓

MDT

82.73

-3.85%↓

A

121.14

+0.35%↑

VEEV

167.39

-1.4%↓

HQY

85.47

-0.71%↓

NEOG

9.39

-1.78%↓

MDT

82.73

-3.85%↓

A

121.14

+0.35%↑

VEEV

167.39

-1.4%↓

HQY

85.47

-0.71%↓

NEOG

9.39

-1.78%↓

Home・Elenco Azioni・Nektar Therapeutics

Search

Nektar Therapeutics

Aperta

97.82 -5.94

Panoramica

Variazione del prezzo dell'azione

24h

Corrente

Minimo

98.51

Massimo

105.65

Metriche Chiave
By Trading Economics
Entrata	-557K -36M
Vendite	10M 22M
EPS	-1.29
Margine di Profitto	-165.447
Dipendenti	63
EBITDA	10M -19M

Raccomandazioni
By TipRanks
Raccomandazioni	Fortemente da comprare
Previsioni per 12 mesi	+37.9% upside

Dividendi
By Dow Jones
Utili prossimi	7 mag 2026

Statistiche di mercato
By TradingEconomics
Capitalizzazione di Mercato	373M 2.3B
Apertura precedente	103.76
Chiusura precedente	97.82

Punteggio Tecnico

By Trading Central

Fiducia

Strong Bearish Evidence

0.5949 / 0.7406 Supporto e resistenza

Nektar Therapeutics Grafico

Le prestazioni passate non sono un indicatore affidabile dei risultati futuri.

Notizie correlate

20 apr 2026, 23:49 UTC

Principali Notizie su Eventi

New Zealand 1Q Inflation Higher Than Expected

20 apr 2026, 23:10 UTC

Azioni calde

Stocks to Watch: Amazon, Alaska Air Group, BridgeBio Oncology, AXT

20 apr 2026, 22:53 UTC

I principali Market Mover

BridgeBio Oncology Shares Rise After FDA Fast-Tracks Pancreatic Cancer Treatment

20 apr 2026, 23:45 UTC

Discorsi di Mercato

Nikkei May Rise on Hopes for U.S.-Iran Peace Talks -- Market Talk

20 apr 2026, 23:44 UTC

Discorsi di Mercato

Gold Consolidates as End of Cease-Fire Looms -- Market Talk

20 apr 2026, 23:39 UTC

Discorsi di Mercato

Rio Tinto Posts Strong Start to Year -- Market Talk

20 apr 2026, 23:30 UTC

Discorsi di Mercato

Global Forex and Fixed Income Roundup: Market Talk

20 apr 2026, 23:30 UTC

Discorsi di Mercato

Global Equities Roundup: Market Talk

20 apr 2026, 23:30 UTC

Discorsi di Mercato

Super Retail's Earnings Outlook Less Rosy -- Market Talk

20 apr 2026, 23:09 UTC

Discorsi di Mercato

Viva Energy's Refinery Fire More Benign Than Jefferies Thought -- Market Talk

20 apr 2026, 22:31 UTC

Acquisizioni, Fusioni, Takeovers

Anthropic, Amazon Tighten Bond in $5 Billion Investment and Computing Deal -- WSJ

20 apr 2026, 22:26 UTC

Acquisizioni, Fusioni, Takeovers

West African Resources Says Sanbrado, Toega Operations Not Subject to Govt Request for Additional Participation

20 apr 2026, 22:25 UTC

Acquisizioni, Fusioni, Takeovers

West African Resources Plans to Distribute Cash Proceeds to Shareholders Via Special Dividend

20 apr 2026, 22:25 UTC

Acquisizioni, Fusioni, Takeovers

West African Resources Aims for Acquisition to Be Completed by End-2026

20 apr 2026, 22:25 UTC

Acquisizioni, Fusioni, Takeovers

West African Resources Says to Work Cooperatively With Govt to Finalize Deal Terms

20 apr 2026, 22:25 UTC

Acquisizioni, Fusioni, Takeovers

West African Resources Says Acquisition Would Be for A$175 Million

20 apr 2026, 22:24 UTC

Acquisizioni, Fusioni, Takeovers

West African Resources Says Burkina Faso Govt Issues Decree to Acquire 25% of Kiaka

20 apr 2026, 22:15 UTC

Acquisizioni, Fusioni, Takeovers

Anthropic, Amazon Tighten Bond in $5 Billion Investment and Computing Deal -- WSJ

20 apr 2026, 22:01 UTC

Acquisizioni, Fusioni, Takeovers

Amazon Invests $5B in Anthropic Amid Expanded Collaboration

20 apr 2026, 21:38 UTC

Discorsi di Mercato

Apple's New CEO Will Face Immediate Pressure on AI Strategy -- Market Talk

20 apr 2026, 21:33 UTC

Acquisizioni, Fusioni, Takeovers

Uber Expands Stake In Lucid for Robo-Taxis. This Is How Tesla's Stock Is Responding. -- Barrons.com

20 apr 2026, 21:24 UTC

Discorsi di Mercato

Apple's CEO Change Timing Will Garner Mixed Reaction, Analyst Says -- Market Talk

20 apr 2026, 21:24 UTC

Discorsi di Mercato

Global Equities Roundup: Market Talk

20 apr 2026, 21:13 UTC

Utili

Alaska Air: Expansion of Card Portfolio Expected to Accelerate Loyalty Platform Beyond Incremental $150M Profit Outlined in Alaska Accelerate Strategy

20 apr 2026, 21:10 UTC

Utili

Alaska Air to Move Toward a Single Issuer for Atmos Rewards Credit Cards

20 apr 2026, 21:09 UTC

Utili

Alaska Air Sees 2Q Capacity Up About 1% Year-Over-Year, Down Nearly a Point From Original Views, on 'Proactive Trimming' of May and June Capacity

20 apr 2026, 21:08 UTC

Utili

Alaska Air 'Continues to Operate From a Position of Strength,' With Healthy Balance Sheet, Strong Liquidity, About $20B in Unencumbered Assets

20 apr 2026, 21:07 UTC

Utili

Alaska Air: Taken Together, Rev, Cost and Fuel Assumptions Result in 2Q Adjusted Loss Per Share Estimate of About $1

20 apr 2026, 21:05 UTC

Utili

Alaska Air: This Assumption Adds About $600M of Expense to 2Q, Equivalent to EPS Headwind of $3.60

20 apr 2026, 21:05 UTC

Utili

Alaska Air Expects 2Q Fuel Cost to Average About $4.50 Based on Forward Curve Today

Confronto tra pari

Modifica del prezzo

Nektar Therapeutics Previsione

Obiettivo di Prezzo

By TipRanks

37.9% in crescita

Previsioni per 12 mesi

Media 138.38 USD 37.9%

Alto 185 USD

Basso 95 USD

Basato su 8 analisti di Wall Street che offrono Obiettivi di Prezzo a 12 mesi per Nektar Therapeutics - Dist negli ultimi 3 mesi.

Consenso sulla valutazione

By TipRanks

Fortemente da comprare

8 ratings

7

Acquista

1

Mantieni

0

Vendi

Basato sugli analisti di 8 che hanno fornito valutazioni azionarie a Nektar Therapeutics - Dist negli ultimi 3 mesi.

Punteggio Tecnico

By Trading Central

0.5949 / 0.7406Supporto e resistenza

Recent bearish events outweigh bullish events.

All events are bearish.

All events are bearish.

Notizie finanziarie

Spese di vendita e di amministrazione

Spese operative

Utile prima delle imposte

Vendite

Costo delle vendite

Utile lordo sulle vendite

Interessi passivi sul debito

EBITDA

Utile operativo

$

Altri titoli del settore

MDT

Medtronic PLC

82.73

A

Agilent Technologies Inc

121.14

VEEV

Veeva Systems Inc

167.39

HQY

HealthEquity Inc

85.47

NEOG

Neogen Corp

9.39

Live chat